Greenhaven Associates Inc. Buys 2,189,083 Shares of Avantor, Inc. $AVTR

Greenhaven Associates Inc. grew its stake in shares of Avantor, Inc. (NYSE:AVTR) by 12.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 20,500,653 shares of the company’s stock after purchasing an additional 2,189,083 shares during the period. Avantor comprises about 3.8% of Greenhaven Associates Inc.’s holdings, making the stock its 7th biggest holding. Greenhaven Associates Inc.’s holdings in Avantor were worth $234,937,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also modified their holdings of AVTR. GAMMA Investing LLC raised its holdings in Avantor by 23.2% during the 4th quarter. GAMMA Investing LLC now owns 8,527 shares of the company’s stock worth $98,000 after buying an additional 1,603 shares during the period. JPMorgan Chase & Co. lifted its stake in Avantor by 5.3% during the third quarter. JPMorgan Chase & Co. now owns 1,806,512 shares of the company’s stock valued at $22,545,000 after buying an additional 91,254 shares in the last quarter. AIA Group Ltd acquired a new position in shares of Avantor in the third quarter worth about $708,000. Manhattan West Asset Management LLC boosted its holdings in shares of Avantor by 65.3% in the third quarter. Manhattan West Asset Management LLC now owns 223,392 shares of the company’s stock worth $2,788,000 after buying an additional 88,241 shares during the period. Finally, Voss Capital LP increased its position in shares of Avantor by 905.6% in the third quarter. Voss Capital LP now owns 4,525,000 shares of the company’s stock worth $56,472,000 after acquiring an additional 4,075,000 shares in the last quarter. Institutional investors and hedge funds own 95.08% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on AVTR shares. Barclays restated an “underweight” rating and set a $8.50 price target on shares of Avantor in a report on Friday, March 6th. Jefferies Financial Group reaffirmed an “underperform” rating and issued a $8.00 price objective on shares of Avantor in a research note on Thursday, February 12th. Citigroup cut their target price on shares of Avantor from $13.00 to $11.00 and set a “neutral” rating on the stock in a research note on Thursday, February 12th. TD Cowen restated a “hold” rating on shares of Avantor in a report on Thursday, February 12th. Finally, Bank of America cut Avantor from a “buy” rating to a “neutral” rating and set a $13.00 target price for the company. in a research report on Monday, December 15th. Three investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $11.80.

Avantor Price Performance

NYSE AVTR opened at $7.51 on Friday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.78 and a quick ratio of 1.18. The firm has a market capitalization of $5.12 billion, a price-to-earnings ratio of -9.62, a price-to-earnings-growth ratio of 2.99 and a beta of 0.97. The company has a 50 day simple moving average of $9.92 and a 200-day simple moving average of $11.49. Avantor, Inc. has a 52-week low of $7.39 and a 52-week high of $16.78.

Avantor (NYSE:AVTR) last announced its quarterly earnings data on Wednesday, February 11th. The company reported $0.22 EPS for the quarter, beating analysts’ consensus estimates of $0.21 by $0.01. The firm had revenue of $1.66 billion for the quarter, compared to the consensus estimate of $1.64 billion. Avantor had a negative net margin of 8.09% and a positive return on equity of 10.45%. The firm’s revenue was down 1.4% on a year-over-year basis. During the same period in the previous year, the firm posted $0.27 earnings per share. Avantor has set its FY 2026 guidance at 0.770-0.830 EPS. Equities research analysts predict that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Insider Activity

In other news, Director Gregory L. Summe acquired 100,000 shares of the business’s stock in a transaction that occurred on Thursday, February 12th. The stock was acquired at an average cost of $9.40 per share, for a total transaction of $940,000.00. Following the completion of the acquisition, the director owned 400,000 shares in the company, valued at approximately $3,760,000. The trade was a 33.33% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Gregory T. Lucier acquired 50,000 shares of Avantor stock in a transaction that occurred on Thursday, February 19th. The shares were purchased at an average cost of $9.16 per share, with a total value of $458,000.00. Following the transaction, the director owned 50,000 shares of the company’s stock, valued at approximately $458,000. The trade was a ∞ increase in their position. The SEC filing for this purchase provides additional information. Insiders have purchased a total of 275,000 shares of company stock worth $2,399,250 in the last ninety days. Corporate insiders own 1.20% of the company’s stock.

About Avantor

Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.

Avantor’s offerings are organized across two primary segments.